Blueprint Genetics
Healthcare Services · Finland · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Keilaranta 16 a-b, Espoo, Uusimaa, 02150...Phone Number
+358 402511372Website
www.blueprintgenetics.comRevenue
$21.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
6
2
3
2
2
1
About Blueprint Genetics
Blueprint Genetics, founded in 2012 and based in Helsinki and Seattle, is in the field of clinical genetic testing of rare inherited diseases.Explore more
Blueprint Genetics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Blueprint Genetics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Blueprint Genetics is spiking on competitors!
Earning: See what the market has to say on Blueprint Genetics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Blueprint Genetics
Click to see if Blueprint Genetics had a recent Job posting/layoffs
Check if Blueprint Genetics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Blueprint Genetics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Blueprint Genetics launches new products
Funding: Get notified immidiatlly once Blueprint Genetics has new funding data
Recommended Actions
Find VP level buyers at Blueprint Genetics
Find 3 more new buyers
Company Profile Activity
Activity Insights
Blueprint Genetics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Blueprint Genetics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Blueprint Genetics.
Blueprint Genetics financials insights
Gather financial insights about Blueprint Genetics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Unspecified
$3.9M
2016
Other Financing Round
$6.3M
2017
Private Equity
$16M
Blueprint Genetics Tech Stack
A closer look at the technologies used by Blueprint Genetics
Most Recent Scoops
Event
will be attending the European Human Genetics Conference 2023 conference as an exhibitor. The event will occur from June 10 to June 13, 2023.
Facilities Relocation / Expansion
Blueprint Genetics is planning to move its offices in May 2023. The move will impact approximately 20 employees at their existing office located at 2505 3Rd Ave Trianon Building, Suite# 204, Seattle, WA.
Mergers & Acquisitions (M&A)
Blueprint Genetics announced its acquisition by Quest Diagnostics, a provider of diagnostic information. The terms of the transaction were not disclosed.
Mergers & Acquisitions
Open Position
Blueprint Genetics is seeking a Marketing Manager. (Seattle, WA)
Seeking Replacement, Personnel Moves
Left Company
Executive Move
Executive Moves, Personnel Moves, Left Company
Blueprint Genetics News & Media
Akouos and Blueprint Genetics Announce the Resonate Program to Improve Access to Genetic Testing for Individuals with Auditory Neuropathy
BOSTON, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Akouos, Inc. (“Akouos”) (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with disabling hearing loss worldwide, and Blueprint Genetics, a Quest Diagnostics company, today announced the Resonate program. The program offers genetic testing to eligible individuals with auditory neuropathy at no cost to participants, their insurance, or their healthcare providers.AGTC Joins the My Retina Tracker® Program as a New Scientific Collaborator
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Oct. 07, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (AGTC), Blueprint Genetics, and Foundation Fighting Blindness, announce today that AGTC, a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, will join the My Retina Tracker® Program as a new scientific collaborator to enhance development of its investigational gene therapies for inheritedQuest Diagnostics Acquires Blueprint Genetics to Broaden Access to Actionable Insights for Genetic and Rare Diseases
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has acquired Blueprint Genetics in an all-cash equity transaction. Blueprint Genetics is a leading specialty genetic testing company with deep expertise in gene variant interpretation based on next generation sequencing (NGS) and proprietary bioinformatics. Together, Quest and Blueprint Genetics will broaden access to actionable insights in genetic and rare diseases, improvingQuest Diagnostics Acquires Blueprint Genetics to Broaden Access to Actionable Insights for Genetic and Rare Diseases
SECAUCUS, N.J. and HELSINKI, Finland, Jan. 22, 2020 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has acquired Blueprint Genetics in an all-cash equity transaction. Blueprint Genetics is a leading...
Read more news
Top Healthcare Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Blueprint Genetics
Sign Up For FreeTo access detailed company insights
Blueprint Genetics, founded in 2012 and based in Helsinki and Seattle, is in the field of clinical genetic testing of rare inherited diseases.... Read More
